Rice Hall James & Associates’s Alkermes ALKS Stock Holding History

Rice Hall James & Associates’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.5M	Buy	390,866 +522	+0.1%	+$20.4K	1%	31
2026 Q1	$13.8M	Buy	390,344 +10,886	+3%	+$338K	0.77%	41
2025 Q4	$10.6M	Sell	379,458 -5,884	-2%	-$176K	0.58%	51
2025 Q3	$11.6M	Sell	385,342 -36,543	-9%	-$1.03M	0.63%	49
2025 Q2	$12.1M	Sell	421,885 -4,700	-1%	-$140K	0.65%	45
2025 Q1	$14.1M	Sell	426,585 -3,342	-0.8%	-$109K	0.83%	37
2024 Q4	$12.4M	Sell	429,927 -21,730	-5%	-$625K	0.68%	45
2024 Q3	$12.6M	Sell	451,657 -16,102	-3%	-$429K	0.68%	44
2024 Q2	$11.3M	Buy	467,759 +66,950	+17%	+$1.64M	0.68%	43
2024 Q1	$10.8M	Buy	400,809 +380,507	+1,874%	+$10.8M	0.62%	48
2023 Q4	$563K	Buy	+20,302	New	+$527K	0.03%	240

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Rice Hall James & Associates's ALKS Position: Q2 2026 in Review

Rice Hall James & Associates increased its Alkermes (ALKS) stake by 0.13% in Q2 2026, buying an estimated $20.4K and bringing the position to 390,866 shares worth $20.5M. The position accounts for 1% of the portfolio, ranked #31.

Rice Hall James & Associates first reported a position in ALKS in Q4 2023 and has held it in 11 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Rice Hall James & Associates held 390,866 shares of Alkermes worth $20.5M as of Q2 2026.
Rice Hall James & Associates bought 522 Alkermes shares in Q2 2026, an estimated $20.4K.
Alkermes made up 1% of Rice Hall James & Associates's portfolio in Q2 2026, its #31 holding.
Rice Hall James & Associates first reported a position in Alkermes in Q4 2023 and has held it in 11 quarters since.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.